Jason Adler
Hematology & Oncology · South Portland, MENPI 1194252148
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 13.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $714 and has fallen 50.5% since, to $353 in 2025.
Across 84 payments — averaging $21.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$236
- AstraZeneca$131
- Blueprint Medicines Corporation$114
- Sanofi$99
- Bristol Myers Squibb$92
- AVEO Pharmaceuticals, Inc.$90
- plus $1K from 23 others
What the payments were for
- Food & beverage$1,69795%
- Education$905%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 12 | $236 |
| AstraZeneca(2 entities) | 7 | $131 |
| Blueprint Medicines Corporation | 4 | $114 |
| Sanofi | 5 | $99 |
| Bristol Myers Squibb | 5 | $92 |
| AVEO Pharmaceuticals, Inc. | 1 | $90 |
| Genmab U.S., Inc. | 4 | $87 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $87 |
| Incyte Corporation | 4 | $85 |
| Daiichi Sankyo Inc. | 3 | $83 |
| Seagen Inc. | 4 | $76 |
| Merck | 4 | $72 |
| AbbVie | 3 | $72 |
| Pfizer | 4 | $71 |
| Amgen | 2 | $48 |
| Boehringer Ingelheim | 2 | $48 |
| Genentech USA, Inc. | 2 | $38 |
| Eisai Inc. | 2 | $35 |
| Array Biopharma Inc | 2 | $29 |
| Lilly USA, LLC | 1 | $27 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $23 |
| Sobi, Inc | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Beone Medicines USA, Inc. | 1 | $20 |
| Gilead | 1 | $20 |
| Morphosys, US Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Bayer | 1 | $13 |
How this compares
$1,787 in reported general payments places this provider in the 60th percentile of 60 hematology & oncology providers in Maine.
Other hematology & oncology in South Portland
- Jason MoranSouth Portland$18K
- Judit GellenSouth Portland$11K
- Pamela EganSouth Portland$471
- Michael AusterSouth Portland$258
- Sarah KetchumSouth Portland$60
- Xiao HuSouth Portland$30
- Matthew DuganWestbrook$577K
- John WintersWestbrook$341K
- Helen RyanKennebunk$83K
- Eleni NackosWestbrook$79K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.